Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer

This study has been completed.
National Cancer Center, Korea
Seoul National University Bundang Hospital
Seoul National University Hospital
Gachon University Gil Medical Center
Yonsei University
Asan Medical Center
Chonnam National University Hospital
Information provided by (Responsible Party):
Young Suk Park, Samsung Medical Center Identifier:
First received: May 12, 2008
Last updated: June 12, 2013
Last verified: June 2013